Tags: ackman | pershing square | valeant | tax

Ackman's Pershing Square Trims Valeant Position for Tax Savings

Ackman's Pershing Square Trims Valeant Position for Tax Savings
(Dollar Photo Club)

Friday, 01 January 2016 07:51 PM

Bill Ackman, the activist investor who has been a staunch defender of Valeant Pharmaceuticals International Inc., trimmed his fund’s holdings of the stock for tax reasons.

Ackman’s Pershing Square Capital Management sold about 5 million shares of Valeant in order to create a tax loss for investors in two accounts, according to a regulatory filing on Thursday. The fund retained its stake in two accounts that wouldn’t get the same tax advantage. Annual losses on investments can be used to lower investors’ total U.S. taxes in some cases, according tothe Internal Revenue Service.

Pershing Square disclosed last month that it had raised its stake in the company to 9.9 percent. After the stock sale, it now holds 8.5 percent, leaving it as the second-largest shareholder behind Ruane Cunniff & Goldfarb Inc., according to data compiled by Bloomberg. The sales began on Dec. 24, one day before Valeant disclosed that Chief Executive Officer Michael Pearson was being treated for severe pneumonia, and they continued every day this week.

Pershing Square spokesman Fran McGill declined to comment beyond the filing.

Valeant’s shares have been battered as the company faced criticism over price increases on older drugs and a now-terminated relationship with a mail-order pharmacy, Philidor Rx Services, that helped boost insurer reimbursement. Ackman has been a vigorous backer of the company. He spent four hours in October arguing that it was undervalued, to little avail.

Valeant fell 68 cents to $101.65 on Thursday in New York trading. The shares have plunged 61 percent since setting a record closing high of $262.52 on Aug. 5.


© Copyright 2020 Bloomberg News. All rights reserved.


   
1Like our page
2Share
InvestingAnalysis
Bill Ackman, the activist investor who has been a staunch defender of Valeant Pharmaceuticals International Inc., trimmed his fund's holdings of the stock for tax reasons.Ackman's Pershing Square Capital Management sold about 5 million shares of Valeant in order to create a...
ackman, pershing square, valeant, tax
262
2016-51-01
Friday, 01 January 2016 07:51 PM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved